Legal Change Beckons After EU Active Substance Master File Pilot Success
Executive Summary
A voluntary pilot that allowed EU regulators to share their assessments of active substance master files (ASMFs) has been a success. Efforts are now underway to change the EU legislation to establish the ASMF as a stand-alone document in order to permit such work sharing on a mandatory basis.
You may also be interested in...
Generics Industry Flags Up 'Duplication' And 'Redundancies' In EU Regulatory Systems
Over the 50 years that the EU pharmaceutical legislation has been in place, great progress has been made in terms of improving the quality, safety and efficacy of medicines, and a significant effort has been expended in building a strong European regulatory structure and harmonized European standards.
Generic drug makers invited to trial international approval pathway
Generic drug makers are being invited to participate in an international pilot program that could enable them to obtain authorization to market their products at roughly the same time in the EU and in one or more of the following countries: Australia, Canada, Taiwan or Switzerland.
EMA issues additional guidance on active substance master file procedure
The European Medicines Agency has issued additional guidance on how drug companies should prepare their active substance master files (ASMFs) to ensure EU competent authorities are able to identify and track where the same file is being used in multiple drug evaluation procedures1.